US Patent Issued to Rutgers, The State University of New Jersey on May 20 for "Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections" (New Jersey Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,562, issued on May 20, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.).

"Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections" was invented by Abraham Pinter (Lakewood, N.J.), Alok K. Choudhary (Plainsboro, N.J.) and Deendayal Patel (Bloomfield, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention broadly provides different compositions, kits, vectors, and methods including monoclonal antibodies directed to epitopes found within lipoarabinomannan (LAM) and phosphatidyl-myo-inositol mannoside 6 (PIM6) for the diagnosis and treatment...